Medical economics and the assessment of value in cardiovascular medicine: Part II.
about
Outcomes following percutaneous coronary intervention and coronary artery bypass grafting surgery in Chinese, South Asian and White patients with acute myocardial infarction: administrative data analysis.Primary prevention of sudden cardiac death: can we afford the cost of cardioverter-defibrillators? Data from the Search-MI Registry-Italian sub-study.Cardioverter-defibrillators after MADIT-II: the balance between weight of evidence and treatment costs.Decision models for assessing the cost effectiveness of drug-eluting stents.Cost-effectiveness as an outcome in randomized clinical trials.Dynamic TIMI risk score for STEMI.Anxiety associations with cardiac symptoms, angiographic disease severity, and healthcare utilization: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation.Assessing the economic attractiveness of coronary artery revascularization in chronic kidney disease patients.Depression and cardiovascular health care costs among women with suspected myocardial ischemia: prospective results from the WISE (Women's Ischemia Syndrome Evaluation) Study.Cost-effectiveness of oral antiplatelet agents--current and future perspectives.Sudden cardiac death and implantable cardioverter defibrillators: two modern epidemics?The cost effectiveness of implantable cardioverter defibrillators: a systematic review of economic evaluations.Cost effectiveness of transcatheter aortic valve replacement compared with medical management or surgery for patients with aortic stenosis.Economic implications of cardiovascular disease management programs: moving beyond one-off experiments.
P2860
Q30724181-073DA964-6DB2-4E84-AC53-814C952C5412Q31085557-E4FBAB17-F2EE-4862-896A-A1C109C9392CQ35201110-FEE7A843-1D7C-460D-BA8C-5A67CD0DC7E8Q36161276-C528ED39-8D25-4E60-9655-9144E7C28AEAQ36684587-2B34FE4A-8F65-447F-99F7-1D5A17CD36A2Q36701761-FA96E1E8-7EB1-479C-9CBD-9BC470DFB872Q36930381-C2B70700-8936-4F82-9740-B5C625136280Q37156721-5C6752FE-B8AB-45FB-AD17-FDC8F6DBD6E1Q37316049-28D8F9FC-CE78-4F3A-85AB-704C68A266EAQ37913974-CA81FA3A-18EA-46DB-89FD-5A7C6D22561DQ37981641-5D0F97A0-B6FB-4653-AB93-1663CFB8F0FEQ38163484-9DBEC865-F49E-472F-B3BE-67AADC48351AQ38285538-C9545BC3-47DA-45AB-8980-1E957FDB4266Q38479575-05619081-34B9-4DD5-8B43-0BF87C63D0E9
P2860
Medical economics and the assessment of value in cardiovascular medicine: Part II.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Medical economics and the assessment of value in cardiovascular medicine: Part II.
@ast
Medical economics and the assessment of value in cardiovascular medicine: Part II.
@en
type
label
Medical economics and the assessment of value in cardiovascular medicine: Part II.
@ast
Medical economics and the assessment of value in cardiovascular medicine: Part II.
@en
prefLabel
Medical economics and the assessment of value in cardiovascular medicine: Part II.
@ast
Medical economics and the assessment of value in cardiovascular medicine: Part II.
@en
P1433
P1476
Medical economics and the assessment of value in cardiovascular medicine: Part II.
@en
P304
P356
10.1161/01.CIR.0000021408.40925.63
P407
P577
2002-07-01T00:00:00Z